Mapping the Safety Profile of BiologicalsA Disproportionality Analysis Using the WHO Adverse Drug Reaction Database, VigiBase

被引:0
|
作者
Thijs J. Giezen
Aukje K. Mantel-Teeuwisse
Ronald H.B. Meyboom
Sabine M.J.M. Straus
Hubert G.M. Leufkens
Toine C.G. Egberts
机构
[1] Utrecht University,Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology
[2] Medicines Evaluation Board,WHO Collaborating Centre for International Drug Monitoring
[3] Uppsala Monitoring Centre,Department of Clinical Pharmacy
[4] University Medical Center Utrecht,undefined
来源
Drug Safety | 2010年 / 33卷
关键词
Infliximab; Etanercept; Adalimumab; Teriparatide; System Organ Class;
D O I
暂无
中图分类号
学科分类号
摘要
Background: Biologicals have specific characteristics, as compared with the small molecule drugs, and carry specific risks. Safety problems, for example infliximab and the risk for tuberculosis, have been identified via spontaneous reports of suspected adverse drug reactions (ADRs). However, in general there is limited data on the nature of spontaneously reported suspected ADRs for biologicals.
引用
收藏
页码:865 / 878
页数:13
相关论文
共 50 条
  • [31] Cardiovascular Toxicities Associated with Anaplastic Lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase)
    Niimura, Takahiro
    Miyata, Koji
    Hamano, Hirofumi
    Nounin, Yuuki
    Unten, Hiroto
    Yoshino, Masaki
    Mitsuboshi, Satoru
    Aizawa, Fuka
    Yagi, Kenta
    Koyama, Toshihiro
    Goda, Mitsuhiro
    Kanda, Yasunari
    Izawa-Ishizawa, Yuki
    Zamami, Yoshito
    Ishizawa, Keisuke
    DRUG SAFETY, 2023, 46 (06) : 545 - 552
  • [32] Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase®)
    Duga, Alemayehu Lelisa
    Salvo, Francesco
    Kay, Alexander
    Figueras, Albert
    ANTIBIOTICS-BASEL, 2023, 12 (05):
  • [33] Disproportionality analysis of cardiac adverse events associated with lenvatinib using the Japanese Adverse Drug Event Report database
    Kanbayashi, Yuko
    Kobayashi, Sakura
    Kojima, Asuka
    Wakabayashi, Haruka
    Shimizu, Tadashi
    Uchida, Mayako
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (12) : 3348 - 3354
  • [34] Disproportionality analysis of the safety profile of rufinamide in the real world: an evaluation of the FDA Adverse Event Reporting System database
    Wang, Lingman
    Gui, Jianxiong
    Zhang, Xiaofang
    Tian, Bing
    Meng, Linxue
    Liu, Jie
    Jiang, Li
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [35] Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBase
    de Campaigno, Emilie Patras
    Kebir, Ines
    Montastruc, Jean-Louis
    Rueter, Manuela
    Maret, Delphine
    Lapeyre-Mestre, Maryse
    Sallerin, Brigitte
    Despas, Fabien
    DRUG SAFETY, 2017, 40 (12) : 1249 - 1258
  • [36] Lupus Associated to TNF-Alpha Inhibitor in Children and Adults: A Disproportionality Analysis in the WHO Pharmacovigilance Database (Vigibase)
    Bouton, Justine
    Moulis, Florence
    Moulis, Guillaume
    Sommet, Agnes
    Rousseau, Vanessa
    Montastruc, Jean-Louis
    Durrieu, Genevieve
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 392 - 392
  • [37] The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase
    Matlala, Mafora F.
    Lubbe, Martha S.
    Steyn, Hanlie
    AFRICAN JOURNAL OF PRIMARY HEALTH CARE & FAMILY MEDICINE, 2023, 15 (01)
  • [38] Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database
    Gastaldon, C.
    Arzenton, E.
    Raschi, E.
    Spigset, O.
    Papola, D.
    Ostuzzi, G.
    Moretti, U.
    Trifiro, G.
    Barbui, C.
    Schoretsanitis, G.
    PSYCHOLOGICAL MEDICINE, 2023, 53 (12) : 5645 - 5653
  • [39] Drug-induced skin ulcer: a disproportionality analysis using data from VigiBase®
    Duron, D.
    Khouri, C.
    Blaise, S.
    Cracowski, J. L.
    Roustit, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 77 - 77
  • [40] Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBase
    Emilie Patras de Campaigno
    Inès Kebir
    Jean-Louis Montastruc
    Manuela Rueter
    Delphine Maret
    Maryse Lapeyre-Mestre
    Brigitte Sallerin
    Fabien Despas
    Drug Safety, 2017, 40 : 1249 - 1258